Table 2. Progress of Acute Treatment.
| All (n = 70) | HAD (n = 29) | Non-HAD (n = 41) | P value | |
|---|---|---|---|---|
| Inotropes use, n (%) | 2 (4) | 2 (7) | 1 (2) | 0.758 |
| IABP, n (%) | 1 (1) | 0 (0) | 1 (2) | 0.999 |
| Ventilator, n (%) | 1 (1) | 1 (3) | 0 (0) | 0.999 |
| NPPV, n (%) | 15 (21) | 8 (28) | 7 (17) | 0.861 |
| CRRT, n (%) | 3 (4) | 2 (7) | 1 (2) | 0.447 |
| Patients admitted to the ICU, n (%) | 9 (13) | 6 (21) | 3 (7) | 0.199 |
| ICU length of stay, days | 0 (0 - 0) | 0 (0 - 0) | 0 (0 - 0) | 0.124 |
| Physical therapy start date | 2 (1 - 3) | 2 (1 - 3) | 1 (1 - 3) | 0.389 |
| Rehabilitation time, min | 180 (100 - 240) | 200 (80 - 260) | 160 (100 - 220) | 0.693 |
| Walking exercise, days | 2 (1 - 4) | 3 (2 - 4) | 2 (1 - 4) | 0.015 |
| Urinary-catheter-placement period, days | 2 (0 - 4) | 3 (1 - 5) | 1 (0 - 2) | 0.019 |
| Intravenous therapy started, days | 4 (2 - 6) | 4 (3 - 6) | 3 (1 - 6) | 0.244 |
| Medication at discharge | ||||
| Beta-blocker, n (%) | 52 (74) | 22 (76) | 30 (73) | 0.999 |
| MRA, n (%) | 36 (37) | 18 (62) | 18 (44) | 0.209 |
| ACEI/ARB, n (%) | 22 (31) | 9 (31) | 13 (32) | 0.999 |
| CCB, n (%) | 19 (27) | 7 (24) | 12 (29) | 0.839 |
| Length of stay, days | 11 (7 - 14) | 12 (7 - 15) | 10 (7 - 14) | 0.470 |
| Return to home rate, n (%) | 61 (87) | 20 (67) | 41 (100) | < 0.01 |
Data are presented as the median (interquartile range). HAD: hospital-acquired disability; IABP: intra-aortic balloon pumping; NPPV: non-invasive positive pressure ventilation; CRRT: continuous renal replacement therapy; ICU: intensive care unit; MRA: mineralocorticoid receptor antagonist; ACEI: angiotensin-converting enzyme inhibitor; ARB: angiotensin II receptor blocker; CCB: calcium channel blocker.